Importantly, anti-CTLA4 treatment induced an immunological memory response with epitope spreading in cured mice, resulting in complete rejection of tumors following rechallenge with immunogenic idMMR or poorly immunogenic pMMR neuroblastoma tumors. This evidence concerns the gene CTLA4 and neuroblastoma.